Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers create pigs resistant to PRRS during reproduction
Researchers found that mothers without the CD163 protein are resistant to the PRRS virus.

Research could save the global pig industry millions

Researchers have used gene editing technology to protect offspring from porcine reproductive and respiratory (PRRS) virus during reproduction.

A study by Kansas State University found that mothers without the CD163 protein are resistant to the PRRS virus and give birth to healthy, normal piglets. The work is published in the journal Scientific Reports.

“We have created a protective shell against the PRRS virus during the reproductive phase of production,” said Bob Rowland, professor of diagnostic medicine and pathobiology at Kansas State University. “The offspring does not become infected during pregnancy and is born a healthy piglet. During this critical phase of production, we have essentially ended a disease.”

PRRS brings about disease in two forms: a respiratory form that makes it more difficult for pigs to breathe and a more severe form that causes mass death in pigs during late pregnancy. Besides having an enormous economic impact, the latter can also have a huge psychological impact on people who work with pigs.

To address the devastating reproductive form of the virus, the researchers set out to create PRRS-resistant pigs. Using CRISPR/Cas9 gene editing technology, they found that pigs without the CD163 protein showed no signs or evidence of being infected with the PRRS virus. CD163 is the receptor for the virus.

The team hopes that the research could save the global pig industry millions because pigs are protected from the PRRS virus during the critical reproductive process. However, because piglets are born normal, they may still be susceptible to disease later in life.

"This is one tool that we can use," Rowland said. "It doesn't mean that we can give up on vaccines or diagnostics, but it does create more opportunities for other tools to become more effective. Because this pig is born healthy, it will respond better to a vaccine or a diagnostic test. We are enhancing other aspects of disease control as well."

Become a member or log in to add this story to your CPD history

Webinar to explore AMR in vet dentistry

News Story 1
 The WSAVA has invited veterinary professionals to a webinar on responsible antibiotic usage in dentistry.

On 19 November 2025, at 1am, Dr J Scott Weese and Dr Brooke Niemiec will share the latest advice for antimicrobial use. They will present research on oral bacterology, and explain how attendees can choose appropriate antibiotics.

The session will cover pre-, intra- and post-operative guidelines, with recommendations for various pathologies.

The webinar is designed to support veterinary professionals to make informed decisions and tackle antimicrobial resistance.

Attendees can register here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com